Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Zoetis Inc. (ZTS)

133.23   -0.72 (-0.54%) 02-28 16:04
Open: 130.4 Pre. Close: 133.95
High: 133.24 Low: 127
Volume: 4,570,959 Market Cap: 63275M
Zoetis Inc is a developer and manufacturer of drugs providing medicines for animal health, and vaccines for livestock and companion animals. Its products are anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 133.487 - 134.245 134.245 - 135.069
Low: 124.926 - 125.745 125.745 - 126.636
Close: 131.618 - 133.104 133.104 - 134.718

Technical analysis

as of: 2020-02-28 4:33:52 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 162.24     One year: 170.83
Support: Support1: 127.00    Support2: 105.66
Resistance: Resistance1: 138.90    Resistance2: 146.26
Pivot: 140.51
Moving Average: MA(5): 135.31     MA(20): 139.66
MA(100): 129.87     MA(250): 118.61
MACD: MACD(12,26): -0.26     Signal(9): 1.14
Stochastic oscillator: %K(14,3): 16.03     %D(3): 13.58
RSI: RSI(14): 37.34
52-week: High: 146.26  Low: 91.21  Change(%): 39.0
Average Vol(K): 3-Month: 203445  10-Days: 229726

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ZTS has closed above bottom band by 5.0%. Bollinger Bands are 63.9% wider than normal. The large width of the bands suggest high volatility as compared to ZTS's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Zoetis to come to market with parasite preventative for dogs
Zoetis (ZTS -0.7%) announces it landed FDA approval for its Simparica Trio tablet. The company says Simparica Trip is the first once-monthly, chewable tabl

Zoetis Receives FDA Approval for Simparica Trio™, A New Combination Parasite Preventative for Dogs
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #Fortune500--Zoetis has received FDA approval for Simparica Trio, a new combination parasite preventative for dogs.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 476.30
Shares Float (M) 474.34
% Held by Insiders 0.24
% Held by Institutions 95.53
Shares Short (K) 5940
Shares Short P. Month (K)

Stock Financials

EPS 3.110
Book Value (p.s.) 5.700
PEG Ratio 3.30
Profit Margin 23.96
Operating Margin 35.03
Return on Assets (ttm) 12.3
Return on Equity (ttm) 61.3
Qtrly Rev. Growth 7.0
Gross Profit (p.s.) 9.175
Sales Per Share
EBITDA (p.s.) 5.417
Qtrly Earnings Growth 11.30
Operating Cash Flow (M) 1800.00
Levered Free Cash Flow (M) 1190.00

Stock Valuations

P/E 42.84
P/E Growth Ratio -0.01
P/BV 23.37
P/S 10.17
P/CF 35.25

Dividends & Splits

Dividend 0.660
Dividend Yield
Dividend Pay Date 2020-03-02
Ex-Dividend Date 2020-04-15
Forward Dividend 0.800
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.